In a recent paper, Trabattoni et al. reported that when compared with healthy subjects, patients with migraine and PFO had an increased procoagulant status secondary to a higher platelet expression of tissue factor and annexin V binding to phosphatidylserine, as well as an increased oxidative stress status, and increased platelet activation (40). This evidence concerns the gene F3 and migraine disorder.